RE: Still relevant17 Feb 2026 07:30
To Bob’s comment this was also illustrated last year with Cidara Therapeutics in the US rising 10-fold once Merck wanted it.
Overall with the timeline to possible news, for me it has derided slightly (as indicated by others) and with the fall back yesterday I’ve decided to take another tranche. High risk, very high reward potential. Let’s see what today and the coming weeks hold